{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T16:38:08Z","timestamp":1794242288845,"version":"4.9.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T00:00:00Z","timestamp":1564012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the Chiba Foundation for Health Promotion & Disease Prevention","award":["18KF0027"],"award-info":[{"award-number":["18KF0027"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1007\/s12282-019-00996-x","type":"journal-article","created":{"date-parts":[[2019,7,25]],"date-time":"2019-07-25T07:33:11Z","timestamp":1564039991000},"page":"77-84","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Histological features of skin and subcutaneous tissue in patients with breast cancer who have received neoadjuvant chemotherapy and their relationship to post-treatment edema"],"prefix":"10.1007","volume":"27","author":[{"given":"Ayako","family":"Nakagawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4987-0715","authenticated-orcid":false,"given":"Hiroshi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nagashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takafumi","family":"Sangai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Takada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahito","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryotaro","family":"Teranaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Ota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Matsushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Akita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Ohtsuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"key":"996_CR1","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1007\/s00520-005-0810-y","volume":"13","author":"SH Ridner","year":"2005","unstructured":"Ridner SH. Quality of life and a symptom cluster associated with breast cancer treatment-related lymphedema. Support Care Cancer. 2005;13:904\u201311.","journal-title":"Support Care Cancer"},{"key":"996_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.critrevonc.2014.06.004","volume":"92","author":"NR Taghian","year":"2014","unstructured":"Taghian NR, Miller CL, Jammallo LS, O\u2019Toole J, Skolny MN. Lymphedema following breast cancer treatment and impact on quality of life: a review. Crit Rev Oncol Hematol. 2014;92:227\u201334.","journal-title":"Crit Rev Oncol Hematol"},{"key":"996_CR3","doi-asserted-by":"publisher","first-page":"2972","DOI":"10.1245\/s10434-017-5960-x","volume":"24","author":"TT Nguyen","year":"2017","unstructured":"Nguyen TT, Hoskin TL, Habermann EB, Cheville AL, Boughey JC. Breast cancer-related lymphedema risk is related to multidisciplinary treatment and not surgery alone: results from a large cohort study. Ann Surg Oncol. 2017;24:2972\u201380.","journal-title":"Ann Surg Oncol"},{"key":"996_CR4","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1002\/bjs.9846","volume":"102","author":"M Cariati","year":"2015","unstructured":"Cariati M, Bains SK, Grootendorst MR, Suyoi A, Peters AM, Mortimer P, et al. Adjuvant taxanes and the development of breast cancer-related arm lymphoedema. Br J Surg. 2015;102:1071\u20138.","journal-title":"Br J Surg"},{"key":"996_CR5","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.4143\/crt.2015.463","volume":"48","author":"M Kim","year":"2016","unstructured":"Kim M, Shin KH, Jung SY, Lee S, Kang HS, Lee ES, et al. Identification of prognostic risk factors for transient and persistent lymphedema after multimodal treatment for breast cancer. Cancer Res Treat. 2016;48:1330\u20137.","journal-title":"Cancer Res Treat"},{"key":"996_CR6","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/S0140-6736(11)61625-5","volume":"379","author":"R Peto","year":"2012","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative G, Peto R, Davies C, Godwin J, Gray R, Pan HC, et al. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials. Lancet. 2012;379:432\u201344.","journal-title":"Lancet"},{"key":"996_CR7","doi-asserted-by":"publisher","first-page":"5542","DOI":"10.1200\/JCO.2005.02.027","volume":"23","author":"SE Jones","year":"2005","unstructured":"Jones SE, Erban J, Overmoyer B, Budd GT, Hutchins L, Lower E, et al. Randomized phase III study of docetaxel compared with paclitaxel in metastatic breast cancer. J Clin Oncol. 2005;23:5542\u201351.","journal-title":"J Clin Oncol"},{"key":"996_CR8","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1200\/JCO.2007.11.6699","volume":"26","author":"AD Seidman","year":"2008","unstructured":"Seidman AD, Berry D, Cirrincione C, Harris L, Muss H, Marcom PK, et al. Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840. J Clin Oncol. 2008;26:1642\u20139.","journal-title":"J Clin Oncol"},{"key":"996_CR9","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/S1470-2045(15)00411-8","volume":"17","author":"T Takashima","year":"2016","unstructured":"Takashima T, Mukai H, Hara F, Matsubara N, Saito T, Takano T, et al. Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial. Lancet Oncol. 2016;17:90\u20138.","journal-title":"Lancet Oncol"},{"key":"996_CR10","doi-asserted-by":"publisher","first-page":"416","DOI":"10.4143\/crt.2014.079","volume":"47","author":"M Kim","year":"2015","unstructured":"Kim M, Park IH, Lee KS, Ro J, Jung SY, Lee S, et al. Breast cancer-related lymphedema after neoadjuvant chemotherapy. Cancer Res Treat. 2015;47:416\u201323.","journal-title":"Cancer Res Treat"},{"key":"996_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1159\/000336480","volume":"82","author":"S Ohsumi","year":"2012","unstructured":"Ohsumi S, Shimozuma K, Ohashi Y, Takeuchi A, Suemasu K, Kuranami M, et al. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02. Oncology. 2012;82:131\u20138.","journal-title":"Oncology"},{"key":"996_CR12","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1089\/lrb.2014.0022","volume":"13","author":"JS Torrisi","year":"2015","unstructured":"Torrisi JS, Joseph WJ, Ghanta S, Cuzzone DA, Albano NJ, Savetsky IL, et al. Lymphaticovenous bypass decreases pathologic skin changes in upper extremity breast cancer-related lymphedema. Lymphat Res Biol. 2015;13:46\u201353.","journal-title":"Lymphat Res Biol"},{"key":"996_CR13","doi-asserted-by":"publisher","first-page":"e8380","DOI":"10.1371\/journal.pone.0008380","volume":"4","author":"K Nakamura","year":"2009","unstructured":"Nakamura K, Radhakrishnan K, Wong YM, Rockson SG. Anti-inflammatory pharmacotherapy with ketoprofen ameliorates experimental lymphatic vascular insufficiency in mice. PLoS ONE. 2009;4:e8380.","journal-title":"PLoS ONE"},{"key":"996_CR14","doi-asserted-by":"publisher","first-page":"363","DOI":"10.2165\/00063030-200620060-00007","volume":"20","author":"L Cheung","year":"2006","unstructured":"Cheung L, Han J, Beilhack A, Joshi S, Wilburn P, Dua A, et al. An experimental model for the study of lymphedema and its response to therapeutic lymphangiogenesis. BioDrugs. 2006;20:363\u201370.","journal-title":"BioDrugs"},{"key":"996_CR15","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/j.jid.2015.12.001","volume":"136","author":"F Ogata","year":"2016","unstructured":"Ogata F, Fujiu K, Matsumoto S, Nakayama Y, Shibata M, Oike Y, et al. Excess lymphangiogenesis cooperatively induced by macrophages and CD4(+) T cells drives the pathogenesis of lymphedema. J Invest Dermatol. 2016;136:706\u201314.","journal-title":"J Invest Dermatol"},{"key":"996_CR16","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00428-017-2260-6","volume":"472","author":"A Moon","year":"2018","unstructured":"Moon A, Smith GH, Kong J, Rogers TE, Ellis CL, Farris ABB 3rd. Development of CD3 cell quantitation algorithms for renal allograft biopsy rejection assessment utilizing open source image analysis software. Virchows Arch. 2018;472:259\u201369.","journal-title":"Virchows Arch"},{"issue":"Supp1","key":"996_CR17","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1186\/1746-1596-6-S1-S5","volume":"6","author":"E Brazdziute","year":"2011","unstructured":"Brazdziute E, Laurinavicius A. Digital pathology evaluation of complement C4d component deposition in the kidney allograft biopsies is a useful tool to improve reproducibility of the scoring. Diagn Pathol. 2011;6(Supp1):S5.","journal-title":"Diagn Pathol"},{"key":"996_CR18","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1002\/micr.30188","volume":"37","author":"S Akita","year":"2017","unstructured":"Akita S, Ogata F, Manabe I, Mitsuhashi A, Nakamura R, Yamaji Y, et al. Noninvasive screening test for detecting early stage lymphedema using follow-up computed tomography imaging after cancer treatment and results of treatment with lymphaticovenular anastomosis. Microsurgery. 2017;37:910\u20136.","journal-title":"Microsurgery"},{"key":"996_CR19","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1007\/s10549-015-3421-4","volume":"151","author":"G Luengo-Gil","year":"2015","unstructured":"Luengo-Gil G, Gonzalez-Billalabeitia E, Chaves-Benito A, Garcia Martinez E, Garcia Garre E, Vicente V, et al. Effects of conventional neoadjuvant chemotherapy for breast cancer on tumor angiogenesis. Breast Cancer Res Treat. 2015;151:577\u201387.","journal-title":"Breast Cancer Res Treat"},{"key":"996_CR20","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1186\/1471-2407-10-137","volume":"10","author":"M Polcher","year":"2010","unstructured":"Polcher M, Rudlowski C, Friedrichs N, Mielich M, Holler T, Wolfgarten M, et al. In vivo intratumor angiogenic treatment effects during taxane-based neoadjuvant chemotherapy of ovarian cancer. BMC Cancer. 2010;10:137.","journal-title":"BMC Cancer"},{"key":"996_CR21","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.imbio.2017.10.050","volume":"223","author":"I Mitrofanova","year":"2018","unstructured":"Mitrofanova I, Zavyalova M, Riabov V, Cherdyntseva N, Kzhyshkowska J. The effect of neoadjuvant chemotherapy on the correlation of tumor-associated macrophages with CD31 and LYVE-1. Immunobiology. 2018;223:449\u201359.","journal-title":"Immunobiology"},{"key":"996_CR22","doi-asserted-by":"publisher","first-page":"1344","DOI":"10.1016\/j.celrep.2016.09.083","volume":"17","author":"D Alishekevitz","year":"2016","unstructured":"Alishekevitz D, Gingis-Velitski S, Kaidar-Person O, Gutter-Kapon L, Scherer SD, Raviv Z, et al. Macrophage-induced lymphangiogenesis and metastasis following paclitaxel chemotherapy is regulated by VEGFR3. Cell Rep. 2016;17:1344\u201356.","journal-title":"Cell Rep"},{"key":"996_CR23","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1093\/toxsci\/kfv017","volume":"145","author":"CH Hung","year":"2015","unstructured":"Hung CH, Chan SH, Chu PM, Tsai KL. Docetaxel facilitates endothelial dysfunction through oxidative stress via modulation of protein kinase c beta: the protective effects of sotrastaurin. Toxicol Sci. 2015;145:59\u201367.","journal-title":"Toxicol Sci"},{"key":"996_CR24","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.1998.16.10.3426","volume":"16","author":"KA Semb","year":"1998","unstructured":"Semb KA, Aamdal S, Oian P. Capillary protein leak syndrome appears to explain fluid retention in cancer patients who receive docetaxel treatment. J Clin Oncol. 1998;16:3426\u201332.","journal-title":"J Clin Oncol"},{"key":"996_CR25","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1046\/j.1365-2125.1997.00613.x","volume":"43","author":"A B\u00e9har","year":"1997","unstructured":"B\u00e9har A, Pujade-Lauraine E, Maurel A, Brun MD, Chauvin FF, Feuilhade de Chauvin F, et al. The pathophysiological mechanism of fluid retention in advanced cancer patients treated with docetaxel, but not receiving corticosteroid comedication. Br J Clin Pharmacol. 1997;43:653\u20138.","journal-title":"Br J Clin Pharmacol"}],"container-title":["Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-019-00996-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12282-019-00996-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12282-019-00996-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T23:29:57Z","timestamp":1595546997000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12282-019-00996-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,25]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["996"],"URL":"https:\/\/doi.org\/10.1007\/s12282-019-00996-x","relation":{},"ISSN":["1340-6868","1880-4233"],"issn-type":[{"value":"1340-6868","type":"print"},{"value":"1880-4233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,25]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"This work was supported by Grants from Chiba Foundation for Health Promotion &\u00a0Disease Prevention. There are no other potential conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from all study participants.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}